Bio Protocol

Highlights and key takeaways from Day 1 of DeSci Berlin 2026👇 → @paulkhls: Drug discovery costs $2.5B and takes 10–15 years per approval. Most of that is bureaucracy, not biology. 90–96% of trials fail and half never get published. → AI-designed peptide binders cost as little as $7 per design run, generating dozens of candidates at once. What used to take months and tens of thousands of dollars now takes hours. The economics of early drug discovery just collapsed by orders of magnitude. → Science is sitting on $21T of untapped real-world asset value, but DeSci's entire ecosystem AUM is only ~$40M. Crypto-native fundraising has already deployed $6.1M across 125 projects with 30,000+ community members and shows that the model works. What's missing is capital. → @vitadao funded @Mykalt45's early research through an IP-NFT-anchored grant. It spun into Aeon Bio , which filed one of the first end-to-end DeSci patents. His other company, CrossBridgeBio, sold to @EliLillyandCo for $300M. → @dermadao sells two real products today, Moon Drops and Sun Drops. Dongsinne Sohn built the project from her personal experience with severe eczema. Chronic skin conditions are too small for pharma and too niche for big beauty, the exact constraint DeSci is positioned to fill. → @foresightinst's warning: Fable 5 access got pulled by export order with 24 hours' notice. If you don't host the model, you don't control your access to it, a hard lesson for anyone building on rented intelligence. Less than 5% of Africa's AI researchers have frontier model access. The gap is growing wider. → For 50 years, the best documented way to extend a mouse's life was calorie restriction, worth about 4 extra months. @aubreydegrey's team matched that by stacking several damage-repair therapies instead, and proved for the first time that the effects compound. Next target: 12 months. Full talks ↓

How does science go from idea to funded execution? At DeSci Berlin, we announced that Bio is building OpenLabs, a coordination and collaboration layer where humans and agents turn scientific ideas into funded execution. What OpenLabs brings: • A shared surface where humans and agents collaborate on scientific ideas • Community voting and coordination that turns posts into funded projects • BioAgents that maintain project continuity and drive research forward Flagship projects include RheumaAI, AI research agent for rheumatology and @peptai_ peptide discovery & more. More soon! Watch the full DeSci Berlin livestream below ↓

Two days of talks on the future of DeSci, AI-driven biotech, agentic science, autonomous drug discovery and more! A huge thank you to our speakers, partners, and everyone who showed up. Couldn't make it this year? Watch the full talks ↓

Revealing what we have been building, live now at DeSci Berlin! Stay tuned.

"From DeSci to Drug Development: How ARTAN Bio and $VITARNA Are Rewriting Biotech Funding to Capture Upside Earlier" Michael @Mykalt45 on stage now talking about the acquisition of his biotech company CrossBridge which was sold to Eli Lilly for up to $300M.

Ben Snipes, Chief Legal Officer @Molecule_sci opens Day 2 of DeSci Berlin! How does it work when token holders can also become equity shareholders holding both simultaneously? Exploring the compliant path from community to cap table.

Day 2 of DeSci Berlin starts NOW! Today's lineup covers biotech funding, encrypted longevity data, peptide discovery, and the legal side of self-driving science. Join us onsite or watch the livestream: x.com/i/broadcasts/1…

DeSci Berlin 2026 - Day 2 x.com/i/broadcasts/1…

That's a wrap on day 1 at DeSci Berlin! Thanks for following along. Day 2 brings drug development funding, peptide discovery, encrypted longevity data, and the legal side of self-driving science. See tomorrow's agenda ↓

We're back LIVE for the afternoon sessions of DeSci Berlin with speakers from @dermadao, @foresightinst, @Molecule_sci and more! Join us onsite or tune into the livestream: x.com/BioProtocol/st…

"The Future of Science is Autonomous" The fifth edition of DeSci Berlin has officially been opened by @paulkhls.

We’re LIVE at DeSci Berlin @BerBlockWeek Streaming today's talks on the future of DeSci, AI-driven biotech, agentic science, autonomous drug discovery and more! Full agenda below. WATCH it live ↓

DeSci Berlin 2026 - Day 1 x.com/i/broadcasts/1…

RSVP now: luma.com/desciberlin2026

DeSci Berlin is TOMORROW! Join biotech leaders, scientists, AI researchers exploring the next phase of DeSci + AI. Register to attend or watch the livestream ↓

LIVE NOW! We're talking peptides, autonomous discovery, and what's coming next for PeptAI. Join us: x.com/i/spaces/1OGwb…

Join the @peptai_ team for a science update TODAY! Sharing the latest on pipeline progress, what's advancing to wet lab, and the commercial side of peptides. 🔔Set a reminder ↓

RSVP now: luma.com/desciberlin2026

4 days until @DeSciBerlin is back for its fifth edition, exploring scientific singularity and agentic science. See the full schedule and some of the talks below ↓